| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10910847 | Lung Cancer | 2015 | 7 Pages |
Abstract
These results indicate that the insertion of platinum-doublet chemotherapy might prevent the development of acquired resistance to EGFR-TKIs in patients with advanced NSCLC harboring EGFR mutations.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Shintaro Kanda, Hidehito Horinouchi, Yutaka Fujiwara, Hiroshi Nokihara, Noboru Yamamoto, Ikuo Sekine, Hideo Kunitoh, Kaoru Kubota, Tomohide Tamura, Yuichiro Ohe,